Trustmark National Bank Trust Department Sells 1,147 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Trustmark National Bank Trust Department cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,672 shares of the company’s stock after selling 1,147 shares during the period. Trustmark National Bank Trust Department’s holdings in HCA Healthcare were worth $1,402,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Congress Wealth Management LLC DE raised its stake in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock valued at $312,000 after acquiring an additional 34 shares during the last quarter. Evergreen Private Wealth LLC lifted its holdings in HCA Healthcare by 0.3% during the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after buying an additional 35 shares during the period. Mediolanum International Funds Ltd raised its position in shares of HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after acquiring an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. boosted its holdings in HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after acquiring an additional 40 shares during the last quarter. Finally, Whittier Trust Co. lifted its position in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after purchasing an additional 41 shares during the period. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent analyst reports. KeyCorp decreased their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. StockNews.com lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, April 9th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Finally, Morgan Stanley reduced their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Down 0.6 %

HCA opened at $333.07 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company’s 50-day moving average is $327.53 and its 200 day moving average is $336.07. The firm has a market capitalization of $82.00 billion, a P/E ratio of 15.16, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the business earned $5.90 earnings per share. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare’s payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.